Serum thymus and activation regulated chemokine levels post-lung transplantation as a predictor for the bronchiolitis obliterans syndrome

Clinical and Experimental Immunology

Volumn 154, Issue 2, 2008, Pages 202-208

  Paantjens, A W M ^a   Kwakkel Van Erp, J M ^a   Van Ginkel, W G J ^a   Van Kessel, D A ^b   Van Den Bosch, J M M ^b   Van De Graaf, E A ^a   Otten, H G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Bronchiolitis obliterans syndrome; Lung transplantation; TARC CCL17

Indexed keywords

THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DISEASE FREE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TH2 CELL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; CHEMOKINE CCL17; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PROGNOSIS;

EID: 53349171742     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03764.x     Document Type: Article

References (38)

1. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003 22 : 1007 18.
2. Hertz MI, Mohacsi PJ, Boucek MM et al. The registry of the international society for heart and lung transplantation: past, present and future. J Heart Lung Transplant 2002 21 : 945 9.
3. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the international society for heart and lung transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 2005 24 : 956 67.
4. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998 114 : 1411 26.
5. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997 155 : 789 818.
6. Burke CM, Theodore J, Dawkins KD et al. Posttransplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984 86 : 824 9.
7. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002 166 : 440 4.
8. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
9. Al-Githmi I, Batawil N, Shigemura N et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg 2006 30 : 846 51.
10. Daud SA, Yusen RD, Meyers BF et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007 175 : 507 13.
11. Jaramillo A, Smith MA, Phelan D et al. Adetected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999 67 : 1155 61.
12. Reinsmoen NL, Nelson K, Zeevi A. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation. Transpl Immunol 2004 13 : 63 71.
13. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002 21 : 271 81.
14. Bauwens AM, van de Graaf EA, van Ginkel WG, van Kessel DA, Otten HG. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2006 25 : 416 9.
15. Fields RC, Bharat A, Steward N et al. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 2006 82 : 1596 601.
16. Golocheikine AS, Saini D, Ramachandran S, Trulock EP, Patterson A, Mohanakumar T Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation. Transpl Immunol 2008 18 : 260 3.
17. Del Prete G, De Carli M, D'Elios MM et al. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 1995 182 : 1655 61.
18. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997 272 : 15036 42.
19. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 34.
20. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001 24 : 382 9.
21. Fujisawa T, Fujisawa R, Kato Y et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002 110 : 139 46.
22. Panina-Bordignon P, Papi A, Mariani M et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001 107 : 1357 64.
23. Sekiya T, Miyamasu M, Imanishi M et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000 165 : 2205 13.
24. Hijnen D, De Bruin-Weller M, Oosting B et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004 113 : 334 40.
25. Furukawa H, Nakamura K, Zheng X et al. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004 35 : 35 42.
26. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and ctivationregulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001 107 : 535 41.
27. Kurokawa M, Kokubu F, Matsukura S et al. Effects of corticosteroid on the expression of thymus and ctivationregulated chemokine in a murine model of allergic asthma. Int Arch Allergy Immunol 2005 137 : 60 8.
28. Belperio JA, Keane MP, Burdick MD et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001 108 : 547 56.
29. Bharat A, Narayanan K, Street T et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007 83 : 150 8.
30. Reynaud-Gaubert M, Marin V, Thirion X et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 2002 21 : 721 30.
31. Scholma J, Slebos DJ, Boezen HM et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000 162 : 2221 5.
32. Sekiya T, Tsunemi Y, Miyamasu M et al. Variations in the human Th2-specific chemokine TARC gene. Immunogenetics 2003 54 : 742 5.
33. Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001 194 : 847 53.
34. Lee I, Wang L, Wells AD et al. T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005 201 : 1037 44.
35. Meloni F, Vitulo P, Cascina A et al. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2004 23 : 1053 60.
36. Kwakkel- van Erp JM, Otten HG, Paantjens AWM et al. Soluble CD30 measured after lung transplantation does not predict the bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil based immunosuppressive regimen. J Heart Lung Transplant (in press).
37. Miyazaki E, Nureki S, Ono E et al. Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury. Chest 2007 131 : 1726 34.
38. Meloni F, Solari N, Miserere S et al. Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors. Transpl Immunol 2008 18 : 275 80.